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CytotoxicT-lymphocytes(CTL)arefamousfortheirabilitytokilltumor,allogeneicandvirus-infectedcells.However,anemerging
literature has now demonstrated that CTL also possess the ability to directly recognize and kill bacteria, parasites, and fungi.
Here, we review past and recent ﬁndings demonstrating the direct microbicidal activity of both CD4+ and CD8+ CTL against
various microbial pathogens. Further, this review will outline what is known regarding the mechanisms of direct killing and their
underlying signalling pathways.
1.Introduction
The adverse consequences of the acquired immune deﬁ-
ciencysyndrome(AIDS)orTcellimmunodeﬁciencyprovide
evidence of the vital role of cytotoxic T-lymphocytes (CTL)
in the immune response. Indeed, CTL are well-known
elements of the immune response to virus-infected, tumour
and allogeneic cells [1–3]. More recently, the role of CTL
was expanded signiﬁcantly when the ability to mediate
direct killing of microbial pathogens was identiﬁed. Research
deﬁning the precise mechanisms underlying CTL killing
of microbes, however, is still in its infancy. Remarkably,
granulysin (in contrast to granzymes) has emerged as a
fundamental mediator of microbial killing. The mode of
action of granulysin appears to be through the disruption
of membrane permeability [4]. It follows that granulysin has
been found to insert into the microbial membrane through
ionic interactions between the positively charged amino acid
residues and negatively charged phospholipids. Insertion of
granulysininturndisruptsmembranepermeabilityresulting
intheinﬂuxofﬂuidintothecytoplasmanddeathbyosmotic
lysis [4]. Other mechanisms identiﬁed in the killing of tumor
cells may also play a role, including Ca2+ inﬂux and K+ eﬄux
[5], and activation of a sphingomyelinase associated with the
cell membrane to generate ceramide [6].
CTL killing of extracellular pathogens involves direct
microbial recognition by the CTL (Figure 1(A)). In con-
trast to tumour and virus-infected cells, recognition of
extracellular pathogens occurs through an apparent MHC-
independent mechanism (as microbes have not been found
to express MHC). Successful recognition induces the release
of granulysin which may directly bind and kill the microbe.
In the case of intracellular microbes, CTL must ﬁrst bind to
the infected host cell. These interactions, like recognition of
tumorandvirus-infectedcells,areoftenMHC-restrictedand
antigen-speciﬁc. Binding triggers the release of granulysin,
which must enter the infected host cell for microbial killing
to occur (Figure 1(B)). This is thought to be mediated
throughperforin-generatedporesinthehostcellmembrane.
These pores facilitate the inﬂux of extracellular Ca2+ which
triggers the target cell to endocytose the damaged region
of the membrane and internalize nearby granulysin [7–9].
Alternatively, CTL may mediate lysis of the infected host cells
releasing microbes which may then be recognized and killed
by nearby CTL (Figure 1(C)).
To acquire microbicidal activity, T cells must be primed.
This priming event can occur in response to cytokines
such as T cell growth factors, stimulation by a mitogen,
or antigen-speciﬁc responses. The receptors and signalling
pathways involved in priming may be the same, but also2 Journal of Biomedicine and Biotechnology
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Figure 1: Killing of extracellular and intracellular microbes by CTL. (A) CTL bind to an extracellular microbe (grey) via an unknown
receptor (?) independently of MHC (panel A1). Binding triggers CTL to release granulysin (blue) which binds to and kills the microbe
(panel A2). By contrast, CTL killing of intracellular microbes involves MHC-restricted antigen-speciﬁc recognition of infected host cells.
(B) CTL-host cell interactions induce the release of perforin (green) and granulysin (panel B1). Perforin-generated pores in the host cell
membrane facilitate the inﬂux of extracellular Ca
2+ which induces endocytosis of the membrane region damaged by perforin, along with
nearbygranulysin(panelsB2–B4).Granulysin-containingendosomesfusewithintracellularcompartmentscontainingthemicrobeallowing
granulysin to bind to and kill the microbe (panel B5). (C) Alternatively, CTL induce lysis of an infected host cell causing the release of
intracellular microbes which are then killed by other nearby CTL (panels C1–C3).
might be quite distinct from the receptors and signalling
that lead to immediate killing. Following the priming event,
the microbicidal CTL is then ready to receive the signal that
triggers them to kill the pathogen.
2.DirectKilling of Bacteriaby CTL
One of the earliest studies describing bactericidal CTL came
from investigations with Pseudomonas aeruginosa [10]. T
cellsfrommiceimmunizedwithP. aeruginosa polysaccharide
were stimulated with macrophages from nonimmune mice
with or without the addition of heat-killed bacteria. The T
c e l l sw e r et h e na b l et ok i l ll i v eP. aeruginosa.M a c r o p h a g e s
had to be present during the priming, but surprisingly, heat-
killed bacteria did not. This suggested that the bactericidal
activity of these T cells was dependent on their interaction
with macrophages but did not require presentation of P.
aeruginosa antigens. Supernatants collected from immune T
cells exposed to macrophages and P. aeruginosa were found
to kill P. aeruginosa in addition to Staphylococcus aureus and
Escherichia coli suggesting that these T cells were producing a
soluble bactericidal product.
CTL have also been found to mediate killing of Mycobac-
terium tuberculosis through the release of bactericidal prod-
ucts [11–13]. M. tuberculosis growth was reduced as much as
74% in the presence of CD4+ CTL and 84% in the presence
of CD8+ CTL [12]. When CD8+ CTL were pretreated with
strontium chloride (which depletes granule contents), it
caused a clear reduction in the ability to kill M. tuberculosis
that correlated with a marked decrease in granulysin content
[13].Invitro,puriﬁedgranulysinwasabletokillextracellular
M.tuberculosisinadose-dependentfashion.However,killing
of intracellular M. tuberculosis required the addition ofJournal of Biomedicine and Biotechnology 3
perforin, which was not directly bactericidal, but was able
to lyse M. tuberculosis-infected macrophages. Together this
data suggests that perforin facilitates entry of granulysin into
M. tuberculosis-infected cells where granulysin can access
and kill the intracellular pathogen. In vivo studies have
provided additional support for the conclusion that perforin
is required for CD8+-mediated clearance of M. tuberculosis.
In these studies, irradiated mice infected with M. tuberculosis
were found to have a signiﬁcantly greater bacterial load after
receiving adoptively transferred perforin-deﬁcient CD8+ T
cells compared to wild-type CD8+ T cells [14].
However, for other bacteria, killing can occur indepen-
dently of perforin. Studies conducted with Listeria innocua
support a perforin-independent mechanism in which gran-
ulysin is actively taken up by the infected cell [15]. Both
healthy and L. innocua-infected dendritic cells (DC) were
found to take up recombinant granulysin in a temperature-
sensitive manner, indicative of active internalization. Fur-
thermore, cholesterol depletion abrogated granulysin uptake
and killing of infected DC, suggesting lipid raft involvement.
Thiswasfurthersupportedbydatashowingcolocalizationof
granulysin and cholera toxin (used as a marker of lipid rafts)
during and shortly following uptake. Immunoﬂuorescent
microscopy showed granulysin traﬃcking through the endo-
cytic pathway following internalization. Ninety minutes after
uptake, granulysin was found to colocalize with phagosomes
containing L. innocua DNA. Indeed, granulysin was found to
kill both extracellular L. innocua and L. innocua-infected DC
inadose-dependent manner.Whilegranulysinmayfunction
independently, perforin might also help. Another study
found that perforin treatment (whether simultaneous or
sequential to granulysin treatment) augmented granulysin-
dependent killing of intracellular L. innocua which was not
due to the formation of stable pores in the DC membrane
[16]. Rather, perforin treatment was found to stimulate
a transient change in the plasma membrane permeability
(assessedbyCa2+ inﬂux) thatenhancedfusionofgranulysin-
containing endosomes with phagosomes containing L.
innocua.
CTL killing of Mycobacterium leprae has also been found
to involve granulysin. The highest level of expression of
granulysin occurred in patients aﬄicted with the localized
tuberculoid form, rather than the disseminated lepromatous
form of the disease [17]. This correlation suggests that
granulysin release by CTL may limit the spread and severity
of M. leprae infection. Remarkably, granulysin expression
was mostly limited to CD4+ T cells. CD4+ T cell lines derived
from tuberculoid leprosy lesions were found to lyse M.
leprae infected macrophages and kill intracellular mycobac-
teria. Strontium treatment abrogated both the cytolytic and
bactericidal activity of these CD4+T cells, which suggested
that killing was mediated through the granule-exocytosis
pathway. Blocking Fas using anti-Fas antibody also partially
inhibited the cytolytic activity of two of four CD4+ Tc e l l
lines suggesting that the Fas-FasL pathway may also play
a minor role in the lysis of M. leprae-infected cells. It
followsthattheextentofFas-FasLmediatedlysismaydepend
on the nature of the CTL [18] or the infected target cell
[19].
3.DirectKillingof Parasitesby CTL
Early studies with Schistosoma mansoni described the capac-
ity of CTL to directly kill parasites [20]. T cells stimulated
with phytohemagglutinin (PHA), a mitogenic lectin, as well
as various oxidative mitogens, antigens, and alloantigens
were found to kill schistosomula. Killing was found to
correlate with increased binding to schistosomula suggest-
ing a contact-dependent mechanism. In support of this,
supernatants from PHA-stimulated T cells were ineﬀective at
killing, although the concentration of parasiticidal products
in the supernatants may not have been high enough to medi-
ate an appreciable response. Moreover, it remains unclear
how PHA induces CTL parasiticidal activity. Removal of
PHA prior to incubation of T cells with schistosomula
was found to impair killing suggesting that PHA may
have an ulterior function in addition to stimulating T
cell activation and proliferation. CTL killing of Entameoba
histolytica closely resembled that of Schistosoma mansoni
in many respects [21]. First, nonspeciﬁc activation of T
cells with PHA was found to signiﬁcantly enhance killing
of E. histolytica trophozoites compared to unstimulated
T cells. PHA-stimulated T cells killed as many as 92%
of trophozoites whereas amoebic viability in the presence
of unstimulated T cells remained relatively unchanged
[21]. Second, binding correlated with killing suggesting
a contact-dependent mechanism. Third, and surprisingly,
killing required the continuous presence of PHA, again
alluding to direct participation. One possibility is that PHA
bridges the T cells and E. histolytica. However, bridging the
T cells and Entameoba cannot be the only mechanism by
which PHA participates in killing because at least 18 hours
of preincubation was required to elicit killing. Similarly, in
studies with S. mansoni, pretreatment of schistosomula with
PHA was not suﬃcient to induce parasiticidal activity of
unstimulated T cells [20]. Thus, PHA appears to act both
by activating the T cells as well as possibly functioning as a
bridge for binding.
Speciﬁc activation of T cells isolated from patients
with an amoebic liver abscess with an E. histolytica lysate
also induced killing [22]. In contrast to prior studies with
PHA [20, 21], stimulation with antigens from E. histolytica
was found to augment binding intensity of T cells to the
trophozoites rather than the binding frequency [22]. Thus,
the more important determinants in killing amoeba may
be the binding characteristics of the CTL rather than the
number of CTL bound. The mechanism underlying the
parasiticidal activity of these T cells is poorly understood.
Anti-TNF-αantibodyblockedkillingofimmuneTcellsfrom
mice immunized against E. histolytica, although large doses
of TNF-α did not directly kill the amoeba [23]. These results
demonstrate the complexity of the system and the possible
role of additional mediators.
CTL have also been reported to directly kill the
pathogenic parasite Toxoplasma gondii.C D 8 + Tc e l l sf r o m
mice immunized with P30 (a T. gondii membrane protein)
and subsequently restimulated in vitro with P30 were
found to kill extracellular T. gondii [24]. Unlike studies
conducted with S. mansoni and E. histolytica [20, 21],4 Journal of Biomedicine and Biotechnology
killing of T. gondii appeared to be antigen speciﬁc. P30-
antigen-speciﬁc splenocytes killed signiﬁcantly more T.
gondii than splenocytes stimulated with the mitogenic lectin,
concanavalin A (ConA), despite greater T cell proliferation
in response to ConA [24]. Although antigen stimulation
resulting in microbicidal priming was likely to have been
MHC-restricted,killingwasdirect.Sincethereisnoevidence
for expression of MHC or MHC-like molecules by T. gondii,
this suggests that direct cytotoxicity was MHC-independent.
MHC-unrestricted T cell killing of extracellular T. gondii has
also been reported by others [25]. However, the mechanism
by which antigen-speciﬁcity is accomplished in the absence
of MHC is not yet deﬁned.
CTL responses against intracellular T. gondii, on the
other hand, have been found to proceed through an MHC-
restricted mechanism [26]. Splenocytes from mice immu-
nized against T. gondii mediated killing of both infected
macrophages and intracellular T. gondii [26, 27]. These
activities were found to be mediated by CD8+ T cells.
Concanamycin, an inhibitor of the vacuolar ATPase that is
required to maintain perforin in lytic granules, signiﬁcantly
impaired killing, implicating perforin in the response against
T. gondii [27]. Indeed, perforin has been found to play a
criticalroleinchronictoxoplasmosis.Perforin-deﬁcientmice
chronically infected with T. gondii were found to have a
higher rate of mortality and a greater number of brain cysts
compared to wild-type mice [28], although other studies
came to disparate conclusions [29]. Moreover, the ability of
CD8+ T cells to kill intracellular T. gondii is controversial.
In one study, CD8+ T cells failed to kill T. gondii-infected B
cells as assessed by quantitative PCR of the SAG-1 gene [30].
Further studies will be required to resolve the discrepancy
between these studies.
Emerging from this uncertainly, Plasmodium falciparum
is clearly killed directly by CTL. γδ T cells were found to
kill blood-stage P. falciparum through a contact-dependent
mechanism [31–33]. Killing appeared to be stage-dependent
with extracellular merozoites being the suggested targets
[31, 32]. In vitro studies revealed a correlation between the
parasiticidal activity of the γδ T cells and expression of
granulysin [33]. Treatment of the T cells with antigranulysin
antibody abrogated this activity. Together, this data indicates
that parasiticidal CTL mediate killing of P. falciparum via the
release of granulysin.
4.DirectKillingofFungiby CTL
Several studies have reported the ability of CTL to kill the
opportunistic fungus Candida albicans. IL-2 stimulation of
murine splenocytes was found to induce fungicidal activity
against C. albicans as well as several other Candida species
[34]. Anti-Candida activity required at least 3 days of
priming with IL-2 and peaked at 7 days. The induction of
fungicidal activity correlated with enhanced killing of an
NK cell-resistant tumor cell line. Supernatants taken from
IL-2 stimulated splenocytes had no eﬀect on the growth
of C. albicans suggesting a contact-dependent fungicidal
mechanism. IL-2 stimulated human PBMC were also found
(a)
(b)
Figure 2: Scanning electron micrographs of conjugates formed
between T cells (left) and C. neoformans (right). Magniﬁcation
in both panels is ×16,370. Cells in (a) were labelled with mouse
monoclonal anti-CD3 antibody followed by goat antimouse IgG
bound to latex beads. Latex beads are seen attached to the eﬀector
cell (a). Cells in (b) were labelled with UPC10 as a control IgG2a
followedbygoatantimouseIgGconjugatedtolatexbeads.Onelatex
beadisseenassociatedwiththecryptococcalcell;however,nobeads
attached to the eﬀector cell (b).
to inhibit the growth of C. albicans. Moreover, another study
found that the CD8+ T cells, and not NK1.1+ cells (NK cells),
mediatedfungicidalactivityagainstC.albicansinresponseto
IL-2 [35].
The CTL response against the yeast-like pathogen Cryp-
tococcus neoformans has been described extensively. In one
of the earlier studies, lymphoid cells were isolated after
mice had been immunized with heat-killed C. neoformans
in complete Freund’s adjuvant [36]. The anticryptococcal
activityofthesecellswasmeasuredbyassessingcolonyform-
ing units, and delayed-type hypersensitivity was assessed by
footpad swelling following administration of C. neoformans
antigen. Only lymphoid cells from immunized mice were
found to inhibit the growth of C. neoformans.G r o w t h
inhibition reached as high as 60–80% as assessed by CFU
[36]. Furthermore, the magnitude of the anticryptococcal
activity correlated with the intensity of the delayed-type
hypersensitivity response. T cells within the peripheral
lymphoid compartment were found to be the mediators
of the anticryptococcal activity [36]. In another study, T
cells were observed to interact directly with C. neoformans
in vitro suggesting a contact-dependent mechanism of
killing (Figure 2)[ 37] .H o w e v e r ,b e t w e e n1 1a n d3 5 %o f
T cells were found to bind to C. neoformans suggesting
recognition by a receptor other than the T cell receptor.
Other studies reported similar killing with human peripheral
blood mononuclear cells (PBMC) stimulated with deadJournal of Biomedicine and Biotechnology 5
C. neoformans [38] or cultured for 7 days with IL-2 and
GM-CSF (but not with TNF, IFN-γ, or vitamin D3) [39].
In agreement with prior studies [36, 37], T cells (as well as
NK cells) isolated from the PBMC were found to directly
bind to, and possess fungicidal activity against C. neoformans
after priming with IL-2 [40]. Another study found that
freshly isolated T cells could mediate killing of C. neoformans
without the need for IL-2 stimulation [41]. However, T
cells cultured without IL-2 soon lost their ability to kill,
suggesting that IL-2 is required for T cells to maintain their
fungicidal activity. Treatment of T cells with the proteases
trypsin and bromelain, which have been found to cleave
several receptors on T cells [42], also impaired killing of C.
neoformans suggesting that receptor-ligand interactions were
involved in anticryptococcal activity [41].
InvestigatorshaveaskedwhetherCTLkillCryptococcusor
exert their anticryptococcal activity by inhibiting the growth
of the organism. Studies using the viability dye 3-(4,5-dim-
ethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
showed that C. neoformans failed to demonstrate metabolic
activity after incubation with T cells [43]. C. neoformans also
becomes permeable and labels with propidium iodide after
incubation with CTL providing further evidence for killing
(unpublished observations, Anowara Islam). Furthermore,
CTL can reduce the burden of organisms below the starting
innocula [41, 44], and consistent with previous studies that
suggestedacontact-dependentmechanismofkilling,separa-
tion of T cells and C. neoformans with a porous membrane
during incubation was found to abrogate anticryptococcal
activity [43]. Thus, the burden of evidence is that killing
occurs.
4.1. Eﬀector Mechanisms Used by CTL to Kill Fungi. Early
studies investigating the mechanism of CTL anticrypto-
coccal activity examined possible receptors and eﬀector
mechanisms. Antibody-mediated blockade of various T
cell surface molecules such as LFA-1 and CD3 did not
signiﬁcantly inhibit killing [45]. Similar results were found
using putative ligands to block mannose and hyaluronate
receptors. Together this data suggests that CTL killing of C.
neoformans may proceed through a novel receptor that is yet
to be identiﬁed.
These early studies also examined the role of reactive
hydroxyl radicals [45], which have been suggested to play
a role in eosinophil-mediated killing [46]. Additionally,
cyclooxygenase inhibitors and prostaglandin E2, which have
been found to inhibit NK cell cytotoxicity [47, 48]a n dN F -
κBa c t i v a t i o n[ 49], were assessed. Among the 3 hydroxyl
radical scavengers used, only catechin was found to impair
killing of C. neoformans [45]. Similarly, only 1 (salicylic
acid) of the 3 cycloxygenase inhibitors abrogated killing,
while prostaglandin E2 failed to have any appreciable eﬀect.
One study, however, described an eﬀector mechanism by
which IL-15 stimulated CD8+ CTL kill C. neoformans [44].
In vitro studies have previously shown that IL-15 from
C. neoformans-stimulated monocytes induced T cells to
become anticryptococcal [50]. This led to studies showing
that the anticryptococcal activity of IL-15-stimulated CD8+
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Figure 3: CD8+ T cells are primed for microbicidal activity
following stimulation with C. neoformans mitogen (CnM). Recog-
nition of CnM (presented by accessory cells) by CD4+Tc e l l s
triggers their activation and proliferation. Meanwhile, a reciprocal
signal from CD4+T cells mediated through an unknown receptor-
ligand interaction (?) induces accessory cells to express IL-15,
which in turn primes CD8+ T cells for granulysin expression and
anticryptococcal activity.
T cells correlated with the level of granulysin expression
[44]. Furthermore, both strontium treatment and siRNA
knockdown of granulysin abrogated anticryptococcal activ-
ity, directly implicating granulysin in the CTL response
against C. neoformans. Perforin was not required, as neither
concanamycin A nor EGTA treatment impaired anticrypto-
coccalactivity.TheseresultsareincontrasttoNKcells,which
depend on perforin, but not granulysin for killing [51].
These results were extended using CD8+ T cells puriﬁed
from PBMC that had been stimulated with C. neofor-
mans mitogen (CnM) [44], a protein mitogen within the
cryptococcal cell wall and membrane [52, 53]. Priming
of anticryptococcal activity and granulysin expression by
stimulation with CnM was dependent on CD4+ T cells [44].
Stimulation of PBMC with CnM in the presence of anti-
IL-15 abrogated anticryptococcal activity and granulysin
expression suggesting that the dependence on CD4+ T
cells was mediated through IL-15. However, in the absence
of accessory cells, CD4+ T cells were not suﬃcient to
induce CD8+ T cell anticryptococcal activity and granulysin
expression. Together this data suggests that the proliferating
CD4+ T cells provide a retrograde stimulus to accessory cells
that results in production of IL-15, which then primes CD8+
T cell for granulysin expression and anticryptococcal activity
(Figure 3)[ 44]. Indeed, both CD4+ and CD8+ Tc e l l si nv i v o
have been found to be indispensable for an eﬀective response
to C. neoformans [54–58].
Aside from their role in licensing accessory cells to prime
CD8+ CTL anticryptococcal activity [44], CD4+ T cells have
also been demonstrated to directly kill C. neoformans [59].
Upon stimulation with IL-2, CD4+ T cells increased the
expression of granulysin (but not perforin) which correlated
with increased fungicidal activity. Both strontium treatment
and granulysin siRNA knockdown abrogated CD4+ Tc e l l
killing of C. neoformans.P e r f o r i ni n v o l v e m e n tw a se x c l u d e d
as neither concanamycin A nor perforin knockdown could6 Journal of Biomedicine and Biotechnology
interfere with anticryptococcal activity of CD4+ T cells stim-
ulated with both IL-2 and anti-CD3 antibody (which stim-
ulated both perforin and granulysin expression). Together
this data suggests that CD4+CTL (like CD8+) directly kill C.
neoformans through a granulysin-mediated mechanism.
The high prevalence of serious cryptococcal infection
in HIV-infected patients [60, 61] may be at least partially
due to a defect in this fungicidal activity. Indeed, CD4+
T cells from these patients were found to exhibit defective
killing of C. neoformans [59]. Neither IL-2 nor IL-2 plus
anti-CD3 stimulation could induce granulysin expression
in these patients’ cells. Furthermore, stimulation with IL-
2 alone was suﬃcient to induce perforin expression. These
results suggest that profound dysregulation of perforin and
granulysin expression may account for the failure of CD4+ T
cells from HIV-infected patients to kill C. neoformans.
4.2. Signalling Pathways Used by CTL to Kill Fungi. The sig-
nalling pathways regulating granulysin expression in CD8+
and CD4+ CTL are relatively unknown. In preparation for
killing of fungi, CD4+ T cells were stimulated with IL-2,
which resulted in expression of granulysin [62]. Expres-
sion of granulysin correlated with short-term (0–60 min)
and long-term (1–5 days) phosphorylation of extracellular
signal-regulated kinases (ERK)1/2, p38 mitogen-activated
protein (MAP) kinase, and p54 c-Jun N-terminal kinases
(JNK) as well as the transcription factor signal transduc-
ers and activators of transcription (STAT)5. Meanwhile,
no phosphorylation of the human oncogene Akt (signi-
fying phosphoinositide 3-kinase (PI3K) activation) could
be detected following continuous IL-2 stimulation. Akt
phosphorylation could only be detected when CD4+ Tc e l l s
were stimulated with IL-2 for 3–5 days, rested (24 hours)
and restimulated with IL-2 for 5 min, indicating that PI3K
undergoes a transient activation after initial stimulation with
IL-2. Continuous stimulation of CD4+ T cells with IL-2
was also found to increase expression of the IL-2Rα and
IL-2Rβ subunits of the IL-2 receptor (by day 3) followed
by expression of granulysin (on day 5). Pharmacological
inhibition of Janus kinase (JAK)3/STAT5 or PI3K abrogated
both granulysin expression and anticryptococcal activity
of IL-2 stimulated CD4+ T cells, which correlated with
decreased expression of the IL-2R subunits. Together this
data suggests that granulysin expression requires acquisition
of one or more of the IL-2R subunits. Indeed, blockade of
IL-2Rβ expression using anti-IL-2Rβ antibodies or siRNA
knockdown abrogated granulysin expression in IL-2 stim-
ulated CD4+ T cells. Thus, IL-2 (and perhaps other T cell
growth factors) signals T cells to increase expression of IL-
2Rβ, which is then available for signalling that is necessary
for granulysin expression.
PreviousstudieshaveshownthatCD4+ TcellsfromHIV-
infected patients exhibit dysregulated expression of perforin
a n dg r a n u l y s i n[ 59]. Comparison of IL-2 signalling in CD4+
T cells from healthy donors and patients infected with HIV
revealedtheunderlyingcausetobedefectiveSTAT5andPI3K
signalling [62]. IL-2 stimulation of CD4+ T cells from HIV-
infected patients failed to induce phosphorylation of STAT5
and failed to increase expression of IL-2Rβ. Furthermore, in
contrast to CD4+ T cells from healthy donors, IL-2 failed
to induce phosphorylation of Akt. Together these results
demonstrate a critical role for JAK/STAT and PI3K signalling
in granulysin-mediated killing of C. neoformans by CD4+ T
cells.
The response in CD8+ T cells is similar. In a recent
study, JAK/STAT signalling was also found to be required
for granulysin expression in CD8+ T cells in response to IL-
15 and IL-21 [63]. CD8+ T cells stimulated with either IL-
15 or IL-21 were found to increase granulysin expression,
which correlated with increased phosphorylation of STAT3
and STAT5. IL-15 was found to induce phosphorylation of
both STAT3 and STAT5, while IL-21 only induced phospho-
rylation of STAT3. Pharmacological inhibition and siRNA
knockdown of JAK/STAT signalling was found to abrogate
granulysin expression by CD8+ T cells in response to IL-
15 and IL-21. Together this data indicates that JAK/STAT
signalling regulates granulysin expression by CD8+ Tc e l l s
in response to IL-15 and IL-21. Consistent with previous
studies conducted with CD4+ T cells [59, 62], HIV-infected
CD8+ T cells exhibited reduced phosphorylation of STAT3,
STAT5, and granulysin expression in response to IL-15 and
IL-21 as compared to mock-infected cells [63].
5. Summary
It is clear that both CD4+ and CD8+CTL mediate direct
killing of a wide range of bacterial, parasitic, and fungal
pathogens. Studies demonstrate several key features of the
microbicidal CTL response. First, with rare exceptions,
killing is contact-dependent. Several studies reported a
correlation between the frequency [20, 21] or intensity [22]
of binding and killing. Moreover, microscopy [37, 40, 41]
revealed direct CTL-microbe interactions. Finally, T cells
separated from C. neoformans b yap o r o u sm e m b r a n ew e r e
unable to mediate killing [43]. Contact may induce release
of cytotoxic products by the CTL or provide a microenviron-
ment or concentration at which the cytotoxic product can
be eﬃcacious. The latter may explain why supernatants from
activated T cells were often unable to mediate killing [20, 34,
40, 41]. Second, killing is mediated primarily through the
granule-exocytosis pathway. In many experimental systems,
pretreatmentofCTL withstrontium(whichdepletes granule
contents) was found to abrogate killing [13, 17, 44, 59].
Furthermore, granulysin, a granule constituent [4], has been
implicated in the killing of several microbes [13, 15–17, 33,
44, 59]. Third, killing (at least of extracellular microbes) is
neither antigen-speciﬁc nor MHC-dependent. Nonspeciﬁc
stimulation with T cell growth factors [34, 35, 39, 40, 44, 59]
or mitogenic lectins [20, 21]w a so f t e ns u ﬃcient to prime the
eﬀector cells for killing.
The eﬀector mechanisms at work during microbial
killing by CTL are gradually being unravelled. While gran-
ulysin appears to be highly involved in killing, the role of
perforin and other eﬀector molecules is not as clear. In the
case of extracellular pathogens, perforin has not been found
to play a role in killing [54, 59], although it plays a role inJournal of Biomedicine and Biotechnology 7
direct killing by NK cells [51, 64, 65]. By contrast, killing
of intracellular microbes requires perforin [13, 27], although
some investigations have suggested a perforin-independent
mechanism[15].Tobesure,thistopicdemandstheattention
of future studies.
Muchlessisknownofthesignallingpathways.JAK/STAT
and PI3K signalling have been found to be essential in CTL
killing of C. neoformans [62]. Defective JAK/STAT and PI3K
signalling in CTL from HIV-infected patients [62, 63]m a y
explain why these patients experience such a high incidence
of severe cryptococcal infection.
During the process of evolution, CTL have developed
the ability to speciﬁcally recognize altered self through
complex TCR-MHC interactions. As a consequence, they
havebecometheepitomeofspeciﬁccell-mediatedimmunity.
It is fascinating to now discover that during this process,
CTL have, at the same time, preserved one of the most
rudimentary immune functions of all, namely, the ability
to directly recognize a microbe, bind, and without the help
of antigen presenting cells or other eﬀector cells kill the
invading pathogen with competence and precision.
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